People taking GLP-1 drugs experienced fewer harms if they already had a substance use disorder and those without one were less likely to develop an addiction.
Taking a GLP-1 drug reduced the number of overdoses, drug-related hospitalizations and deaths in people who already had a substance use disorder. It also decreased the risk that someone would develop an active addiction to opioids, cocaine, nicotine, alcohol, cannabis or other substances.